These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9861565)

  • 1. Adverse reactions to tick-borne encephalitis vaccine: FSME-Immun.
    Grzeszczuk A; Sokolewicz-Bobrowska E; Prokopowicz D
    Infection; 1998; 26(6):385-8. PubMed ID: 9861565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules.
    Wittermann C; Schöndorf I; Gniel D
    Vaccine; 2009 Mar; 27(10):1661-6. PubMed ID: 18940221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.
    Loew-Baselli A; Konior R; Pavlova BG; Fritsch S; Poellabauer E; Maritsch F; Harmacek P; Krammer M; Barrett PN; Ehrlich HJ;
    Vaccine; 2006 Jun; 24(24):5256-63. PubMed ID: 16624457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity.
    Ehrlich HJ; Pavlova BG; Fritsch S; Poellabauer EM; Loew-Baselli A; Obermann-Slupetzky O; Maritsch F; Cil I; Dorner F; Barrett PN
    Vaccine; 2003 Dec; 22(2):217-23. PubMed ID: 14615149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
    Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Firth C; Petermann R; Barrett PN; Ehrlich HJ
    Vaccine; 2011 Oct; 29(43):7307-19. PubMed ID: 21843576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the booster interval for the tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' be prolonged? - A systematic review.
    Steffen R; Erber W; Schmitt HJ
    Ticks Tick Borne Dis; 2021 Sep; 12(5):101779. PubMed ID: 34298356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.
    Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Koska M; Bobrovsky R; Konior R; Ehrlich HJ
    Hum Vaccin; 2009 Aug; 5(8):551-6. PubMed ID: 19430202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Active immunization against tick-born encephalitis (TBE) among border guards (1993-2002)].
    Knap J; Ryba S
    Przegl Epidemiol; 2002; 56 Suppl 1():110-6. PubMed ID: 12194224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.
    Prymula R; Pöllabauer EM; Pavlova BG; Löw-Baselli A; Fritsch S; Angermayr R; Geisberger A; Barrett PN; Ehrlich HJ
    Hum Vaccin Immunother; 2012 Jun; 8(6):736-42. PubMed ID: 22699436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.
    Konior R; Brzostek J; Poellabauer EM; Jiang Q; Harper L; Erber W
    Vaccine; 2017 Jun; 35(28):3607-3613. PubMed ID: 28545923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the reactivity and immunogenicity of FSME-IMMUN vaccine against tick-borne meningoencephalitis].
    Borcić B; Majerus-Misić L; Raos B; Punda V; Bujić N; Toth D
    Lijec Vjesn; 1984 Oct; 106(10):425-8. PubMed ID: 6503595
    [No Abstract]   [Full Text] [Related]  

  • 12. [FSME monitoring: monitoring of adverse events of tick-borne-encephalitis vaccines by selected paediatricians and general practitioners].
    Weinzettel R; Ertl S; Zwiauer K
    Wien Med Wochenschr; 2007; 157(5-6):107-10. PubMed ID: 17427006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
    Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
    Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
    Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
    Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Suspected neurological side-effects of tick-borne meningoencephalitis vaccination: experiences of the Swiss Adverse Drug Reaction Reporting Center].
    Doser AK; Hartmann K; Fleisch F; Kuhn M
    Praxis (Bern 1994); 2002 Jan; 91(5):159-62. PubMed ID: 11865774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against tick-borne encephalitis--distant evaluation.
    Bobrowska E; Grzeszczuk A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial.
    Kantele A; Rombo L; Vene S; Kundi M; Lindquist L; Erra EO
    Vaccine; 2022 Feb; 40(9):1299-1305. PubMed ID: 35101266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens.
    Harabacz I; Bock H; Jüngst C; Klockmann U; Praus M; Weber R
    Vaccine; 1992; 10(3):145-50. PubMed ID: 1557929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of antibodies after immunization with the FSME-Immun vaccine].
    Pazdiora P; Januska J; Kubátová A
    Epidemiol Mikrobiol Imunol; 2000 Aug; 49(3):110-4. PubMed ID: 11040492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reactions after vaccination against tick-borne encephalitis].
    Vlasimská H; Smejkalová H
    Epidemiol Mikrobiol Imunol; 1995 Mar; 44(1):26-8. PubMed ID: 7757345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.